180 related articles for article (PubMed ID: 1382996)
1. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
Lesley J; Hyman R
Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
[TBL] [Abstract][Full Text] [Related]
2. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
Lesley J; Kincade PW; Hyman R
Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
[TBL] [Abstract][Full Text] [Related]
3. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
6. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
8. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
[TBL] [Abstract][Full Text] [Related]
9. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
11. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
12. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
13. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid.
Arai K; Iiai T; Nakayama M; Hasegawa K; Sato K; Ohtsuka K; Watanabe H; Hanyu T; Takahashi HE; Abo T
Immunology; 1995 Jan; 84(1):64-71. PubMed ID: 7534265
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of homing receptors after T cell activation.
Jung TM; Gallatin WM; Weissman IL; Dailey MO
J Immunol; 1988 Dec; 141(12):4110-7. PubMed ID: 3058798
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
19. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
20. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis.
Mikecz K; Dennis K; Shi M; Kim JH
Arthritis Rheum; 1999 Apr; 42(4):659-68. PubMed ID: 10211879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]